,X,Filing Date,Trade Date,Ticker,Insider Name,Title,Trade Type,Price,Qty,Owned,ΔOwn,Value,1d,1w,1m,6m,ticker
0,,2022-02-07 17:09:32,2022-02-04,RGLS,Drygin Denis,Chief Scientific Officer,P - Purchase,$0.23,23314,23314,New,"+$5,362",,,,,RGLS
1,D,2022-01-26 16:13:34,2022-01-26,RGLS,Hagan Joseph P,"Pres, CEO",P - Purchase,$0.22,100000,417006,+32%,"+$21,520",,,,,RGLS
2,,2021-12-01 16:12:11,2021-11-30,RGLS,Papadopoulos Stelios,Dir,A - Grant,$0.36,2222222,5061929,+78%,"+$800,000",,,,,RGLS
3,,2021-05-17 19:13:47,2021-05-17,RGLS,Hagan Joseph P,"Pres, CEO",S - Sale,$0.89,-4186,316292,-1%,"-$3,726",,,,,RGLS
4,,2021-05-17 19:12:49,2021-05-17,RGLS,Aker Christopher Ray,"SVP, GC",S - Sale,$0.89,-860,41754,-2%,-$765,,,,,RGLS
5,D,2021-04-16 16:12:40,2021-04-14,RGLS,Hagan Joseph P,"Pres, CEO",C - Converted deriv,$0.00,75850,320478,-19%,$0,,,,,RGLS
6,A,2021-04-16 16:11:19,2021-02-16,RGLS,Hagan Joseph P,"Pres, CEO",S - Sale,$1.72,-4144,244628,-2%,"-$7,128",,,,,RGLS
7,,2021-02-17 17:23:47,2021-02-16,RGLS,Aker Christopher Ray,"SVP, GC",S - Sale,$1.72,-828,42614,-2%,"-$1,424",,,,,RGLS
8,,2021-02-17 17:23:07,2021-02-16,RGLS,Hagan Joseph P,"Pres, CEO",S - Sale,$1.72,-4144,485756,-1%,"-$7,128",,,,,RGLS
9,A,2021-01-27 20:16:24,2020-12-04,RGLS,Papadopoulos Stelios,Dir,A - Grant,$0.63,793528,2839707,+39%,"+$500,002",,,,,RGLS
10,D,2020-12-07 17:14:27,2020-12-04,RGLS,Walker Paul Edward,10%,P - Purchase,$0.62,4398602,6451056,+214%,"+$2,735,930",,,,,RGLS
11,D,2020-12-07 17:13:55,2020-12-04,RGLS,Sonsini Peter W.,10%,P - Purchase,$0.62,4398602,6451056,+214%,"+$2,735,930",,,,,RGLS
12,D,2020-12-07 17:12:51,2020-12-04,RGLS,Sandell Scott D,10%,P - Purchase,$0.62,4398602,6451056,+214%,"+$2,735,930",,,,,RGLS
13,D,2020-12-07 17:12:13,2020-12-04,RGLS,Makower Joshua,10%,P - Purchase,$0.62,4398602,6451056,+214%,"+$2,735,930",,,,,RGLS
14,D,2020-12-07 17:11:36,2020-12-04,RGLS,Makhzoumi Mohamad,10%,P - Purchase,$0.62,4398602,6451056,+214%,"+$2,735,930",,,,,RGLS
15,D,2020-12-07 17:10:46,2020-12-04,RGLS,Florence Anthony A. Jr.,10%,P - Purchase,$0.62,4398602,6451056,+214%,"+$2,735,930",,,,,RGLS
16,D,2020-12-07 17:10:01,2020-12-04,RGLS,Chang Carmen,10%,P - Purchase,$0.62,4398602,6451056,+214%,"+$2,735,930",,,,,RGLS
17,D,2020-12-07 17:09:12,2020-12-04,RGLS,Behbahani Ali,10%,P - Purchase,$0.62,4398602,6451056,+214%,"+$2,735,930",,,,,RGLS
18,D,2020-12-07 17:08:19,2020-12-04,RGLS,Baskett Forest,10%,P - Purchase,$0.62,4398602,6451056,+214%,"+$2,735,930",,,,,RGLS
19,D,2020-12-07 17:06:40,2020-12-04,RGLS,"Growth Equity Opportunities V, LLC",10%,P - Purchase,$0.62,4398602,6451056,+214%,"+$2,735,930",,,,,RGLS
20,D,2020-12-07 16:22:33,2020-12-04,RGLS,Hagan Joseph P,"Pres, CEO",A - Grant,$0.63,39680,225674,+21%,"+$25,002",,,,,RGLS
21,D,2020-12-07 16:21:50,2020-12-04,RGLS,Papadopoulos Stelios,Dir,A - Grant,$0.63,793528,1986729,+67%,"+$500,002",,,,,RGLS
22,,2020-11-18 16:10:55,2020-11-16,RGLS,Aker Christopher Ray,"SVP, GC",S - Sale,$0.52,-876,25762,-3%,-$456,,,,,RGLS
23,,2020-11-18 16:09:52,2020-11-16,RGLS,Hagan Joseph P,"Pres, CEO",S - Sale,$0.52,-6094,215994,-3%,"-$3,176",,,,,RGLS
24,,2020-08-17 20:22:11,2020-08-14,RGLS,Hagan Joseph P,"Pres, CEO",S - Sale,$0.60,-4245,222088,-2%,"-$2,568",,,,,RGLS
25,,2020-08-17 20:21:22,2020-08-14,RGLS,Aker Christopher Ray,"SVP, GC",S - Sale,$0.61,-872,26638,-3%,-$528,,,,,RGLS
26,,2020-05-18 16:28:07,2020-05-15,RGLS,Hagan Joseph P,"Pres, CEO",S - Sale,$0.63,-4426,226333,-2%,"-$2,774",,,,,RGLS
27,,2020-05-18 16:27:10,2020-05-15,RGLS,Aker Christopher Ray,"SVP, GC",S - Sale,$0.63,-909,27510,-3%,-$570,,,,,RGLS
28,,2020-02-19 18:09:57,2020-02-18,RGLS,Hagan Joseph P,"Pres, CEO",S - Sale,$0.83,-4324,230759,-2%,"-$3,591",,,,,RGLS
29,,2020-02-19 18:08:16,2020-02-18,RGLS,Aker Christopher Ray,"SVP, GC",S - Sale,$0.83,-888,28419,-3%,-$737,,,,,RGLS
30,D,2020-02-04 17:05:44,2020-02-03,RGLS,Rastetter William H,Dir,C - Converted deriv,$0.00,225940,390584,-37%,$0,,,,,RGLS
31,D,2020-02-04 16:59:55,2020-02-03,RGLS,Papadopoulos Stelios,Dir,C - Converted deriv,$0.00,846320,2039521,-29%,$0,,,,,RGLS
32,,2020-01-03 16:07:13,2020-01-02,RGLS,Hagan Joseph P,"Pres, CEO",S - Sale,$0.97,-8345,235083,-3%,"-$8,067",,,,,RGLS
33,,2020-01-03 16:06:23,2020-01-02,RGLS,Aker Christopher Ray,"SVP, GC",S - Sale,$0.97,-2239,29307,-7%,"-$2,164",,,,,RGLS
34,,2019-11-15 17:37:39,2019-11-14,RGLS,Aker Christopher Ray,"SVP, GC",S - Sale,$0.64,-833,31546,-3%,-$533,,,,,RGLS
35,,2019-11-15 17:36:57,2019-11-14,RGLS,Hagan Joseph P,"Pres, CEO",S - Sale,$0.64,-5838,243428,-2%,"-$3,736",,,,,RGLS
36,,2019-10-02 18:50:11,2019-10-01,RGLS,Aker Christopher Ray,"SVP, GC",S - Sale,$0.68,-2346,32379,-7%,"-$1,602",,,,,RGLS
37,,2019-10-02 18:17:43,2019-10-01,RGLS,Hagan Joseph P,"Pres, CEO",S - Sale,$0.68,-8743,249266,-3%,"-$5,969",,,,,RGLS
38,,2019-08-16 16:17:23,2019-08-15,RGLS,Hagan Joseph P,"Pres, CEO",S - Sale,$0.55,-4375,258009,-2%,"-$2,409",,,,,RGLS
39,,2019-08-16 16:16:18,2019-08-15,RGLS,Aker Christopher Ray,"SVP, GC",S - Sale,$0.55,-899,34725,-3%,-$495,,,,,RGLS
40,,2019-07-02 17:42:57,2019-07-01,RGLS,Hagan Joseph P,"Pres, CEO",S - Sale,$1.31,-5783,262384,-2%,"-$7,584",,,,,RGLS
41,,2019-07-02 17:42:05,2019-07-01,RGLS,Aker Christopher Ray,"SVP, GC",S - Sale,$1.31,-2225,35624,-6%,"-$2,918",,,,,RGLS
42,,2019-07-02 17:41:20,2019-07-01,RGLS,Chevallard Daniel R.,CFO,S - Sale,$1.31,-2669,77870,-3%,"-$3,500",,,,,RGLS
43,AD,2019-05-21 16:46:13,2019-05-07,RGLS,Papadopoulos Stelios,Dir,A - Grant,$1.08,370370,1189872,+45%,"+$400,000",,,,,RGLS
44,AD,2019-05-21 16:45:05,2019-05-07,RGLS,Rastetter William H,Dir,A - Grant,$1.08,92889,154223,+151%,"+$100,320",,,,,RGLS
45,AD,2019-05-21 16:44:03,2019-05-07,RGLS,Witz Pascale,Dir,A - Grant,$1.08,29630,37849,+361%,"+$32,000",,,,,RGLS
46,AD,2019-05-21 16:42:59,2019-05-07,RGLS,Hagan Joseph P,"Pres, CEO",A - Grant,$1.08,33194,64542,+106%,"+$35,850",,,,,RGLS
47,D,2019-05-16 17:25:41,2019-05-14,RGLS,Hagan Joseph P,"Pres, CEO",A - Grant,$0.00,188385,268167,+236%,+$0,,,,,RGLS
48,D,2019-05-16 17:25:41,2019-05-16,RGLS,Hagan Joseph P,"Pres, CEO",S - Sale+OE,$1.22,-39352,268167,-13%,"-$47,966",,,,,RGLS
49,D,2019-05-16 17:21:46,2019-05-14,RGLS,Chevallard Daniel R.,CFO,A - Grant,$0.00,55414,80539,+221%,+$0,,,,,RGLS
50,D,2019-05-16 17:21:46,2019-05-15,RGLS,Chevallard Daniel R.,CFO,S - Sale+OE,$1.41,-10000,80539,-11%,"-$14,089",,,,,RGLS
51,D,2019-05-16 17:21:16,2019-05-14,RGLS,Aker Christopher Ray,"SVP, GC",A - Grant,$0.00,38512,59309,+185%,+$0,,,,,RGLS
52,D,2019-05-16 17:21:16,2019-05-15,RGLS,Aker Christopher Ray,"SVP, GC",S - Sale+OE,$1.41,-6950,59309,-10%,"-$9,796",,,,,RGLS
53,AD,2019-05-10 10:59:46,2019-05-07,RGLS,Walker Paul Edward,10%,P - Purchase,$1.08,1136704,2052454,+124%,"+$1,227,640",,,,,RGLS
54,D,2019-05-09 18:08:02,2019-05-07,RGLS,Walker Paul Edward,Dir,P - Purchase,$1.08,1136704,2052454,+124%,"+$1,227,640",,,,,RGLS
55,D,2019-05-09 18:07:39,2019-05-07,RGLS,Sonsini Peter W.,10%,P - Purchase,$1.08,1136704,2052454,+124%,"+$1,227,640",,,,,RGLS
56,D,2019-05-09 18:07:17,2019-05-07,RGLS,Sandell Scott D,10%,P - Purchase,$1.08,1136704,2052454,+124%,"+$1,227,640",,,,,RGLS
57,D,2019-05-09 18:06:55,2019-05-07,RGLS,Mott David M,10%,P - Purchase,$1.08,1136704,2052454,+124%,"+$1,227,640",,,,,RGLS
58,D,2019-05-09 18:06:25,2019-05-07,RGLS,Makower Joshua,10%,P - Purchase,$1.08,1136704,2052454,+124%,"+$1,227,640",,,,,RGLS
59,D,2019-05-09 18:05:57,2019-05-07,RGLS,Makhzoumi Mohamad,10%,P - Purchase,$1.08,1136704,2052454,+124%,"+$1,227,640",,,,,RGLS
60,D,2019-05-09 18:05:31,2019-05-07,RGLS,Florence Anthony A. Jr.,10%,P - Purchase,$1.08,1136704,2052454,+124%,"+$1,227,640",,,,,RGLS
61,D,2019-05-09 18:05:07,2019-05-07,RGLS,Chang Carmen,10%,P - Purchase,$1.08,1136704,2052454,+124%,"+$1,227,640",,,,,RGLS
62,D,2019-05-09 18:04:41,2019-05-07,RGLS,Behbahani Ali,10%,P - Purchase,$1.08,1136704,2052454,+124%,"+$1,227,640",,,,,RGLS
63,D,2019-05-09 18:04:17,2019-05-07,RGLS,Baskett Forest,10%,P - Purchase,$1.08,1136704,2052454,+124%,"+$1,227,640",,,,,RGLS
64,D,2019-05-09 18:02:51,2019-05-07,RGLS,Barris Peter J,10%,P - Purchase,$1.08,1136704,2052454,+124%,"+$1,227,640",,,,,RGLS
65,D,2019-05-09 18:02:01,2019-05-07,RGLS,"Growth Equity Opportunities V, LLC",10%,P - Purchase,$1.08,1136704,2052454,+124%,"+$1,227,640",,,,,RGLS
66,D,2019-05-08 17:15:57,2019-05-07,RGLS,Hagan Joseph P,"Pres, CEO",P - Purchase,$1.08,33194,64542,+106%,"+$35,850",,,,,RGLS
67,D,2019-05-08 17:15:09,2019-05-07,RGLS,Witz Pascale,Dir,P - Purchase,$1.08,29630,37849,+361%,"+$32,000",,,,,RGLS
68,D,2019-05-08 17:14:20,2019-05-07,RGLS,Rastetter William H,Dir,P - Purchase,$1.08,92889,154223,+151%,"+$100,320",,,,,RGLS
69,D,2019-05-08 17:13:31,2019-05-07,RGLS,Papadopoulos Stelios,Dir,P - Purchase,$1.08,370370,1189872,+45%,"+$400,000",,,,,RGLS
70,,2019-04-03 16:31:20,2019-04-01,RGLS,Hagan Joseph P,"Pres, CEO",S - Sale,$0.98,-5842,31348,-16%,"-$5,731",,,,,RGLS
71,,2019-04-03 16:16:32,2019-04-01,RGLS,Chevallard Daniel R.,CFO,S - Sale,$0.98,-3253,9372,-26%,"-$3,192",,,,,RGLS
72,,2019-04-03 16:15:51,2019-04-01,RGLS,Aker Christopher Ray,"SVP, GC",S - Sale,$0.98,-2710,6287,-30%,"-$2,659",,,,,RGLS
73,D,2019-02-06 16:52:33,2019-02-05,RGLS,Wright Timothy Michael,"Chief R, D Officer",A - Grant,$0.95,40000,62893,+175%,"+$38,000",,,,,RGLS
74,D,2019-02-06 16:51:39,2019-02-05,RGLS,Hagan Joseph P,"Pres, CEO",A - Grant,$0.95,65000,84148,+339%,"+$61,750",,,,,RGLS
75,D,2019-02-06 16:50:42,2019-02-05,RGLS,Chevallard Daniel R.,CFO,A - Grant,$0.95,30000,34578,+655%,"+$28,500",,,,,RGLS
76,D,2019-02-06 16:49:53,2019-02-05,RGLS,Aker Christopher Ray,"SVP, GC",A - Grant,$0.00,25000,27747,+910%,+$0,,,,,RGLS
77,,2019-01-02 16:12:34,2018-12-28,RGLS,Papadopoulos Stelios,Dir,P - Purchase,$1.09,50000,835073,+6%,"+$54,570",,,,,RGLS
78,M,2018-12-28 16:21:12,2018-12-26,RGLS,Papadopoulos Stelios,Dir,P - Purchase,$0.97,116401,785073,+17%,"+$113,338",,,,,RGLS
79,D,2018-11-21 17:29:48,2018-11-12,RGLS,Papadopoulos Stelios,Dir,A - Grant,$0.00,20910,168672,+14%,+$0,,,,,RGLS
80,M,2018-11-19 16:03:12,2018-11-15,RGLS,Papadopoulos Stelios,Dir,P - Purchase,$1.36,500000,668672,+296%,"+$680,550",,,,,RGLS
81,,2018-11-19 16:01:47,2018-11-16,RGLS,Collier Kathryn J,Dir,P - Purchase,$1.41,7100,27596,+35%,"+$10,011",,,,,RGLS
82,D,2018-11-13 17:35:37,2018-11-12,RGLS,Baltimore David,Dir,A - Grant,$0.00,40339,44131,>999%,+$0,,,,,RGLS
83,D,2018-11-13 17:35:03,2018-11-12,RGLS,Collier Kathryn J,Dir,A - Grant,$0.00,16874,20496,+466%,+$0,,,,,RGLS
84,D,2018-11-13 17:33:29,2018-11-12,RGLS,Rastetter William H,Dir,A - Grant,$0.00,23258,79672,+41%,+$0,,,,,RGLS
85,D,2018-11-13 17:32:52,2018-11-12,RGLS,Rosen Hugh,Dir,A - Grant,$0.00,19245,22756,+548%,+$0,,,,,RGLS
86,D,2018-11-13 17:32:11,2018-11-12,RGLS,Witz Pascale,Dir,A - Grant,$0.00,15833,19625,+418%,+$0,,,,,RGLS
87,D,2018-06-05 16:28:28,2018-06-05,RGLS,Collier Kathryn J,Dir,A - Grant,$0.74,7695,7695,New,"+$5,694",,,,,RGLS
88,D,2018-04-17 16:36:52,2018-04-14,RGLS,Collier Kathryn J,Dir,A - Grant,$0.64,60234,60234,New,"+$38,550",,,,,RGLS
89,,2017-12-06 19:43:16,2017-12-04,RGLS,Baltimore David,Dir,A - Grant,$0.89,60674,60674,New,"+$54,000",,,,,RGLS
90,,2017-12-06 19:42:15,2017-12-04,RGLS,Foletta Mark G,Dir,A - Grant,$0.89,71910,81910,+719%,"+$64,000",,,,,RGLS
91,,2017-12-06 19:41:29,2017-12-04,RGLS,Papadopoulos Stelios,Dir,A - Grant,$0.89,96629,1797306,+6%,"+$86,000",,,,,RGLS
92,,2017-12-06 19:40:44,2017-12-04,RGLS,Rosen Hugh,Dir,A - Grant,$0.89,56179,56179,New,"+$49,999",,,,,RGLS
93,,2017-12-06 19:39:46,2017-12-04,RGLS,Witz Pascale,Dir,A - Grant,$0.89,60674,60674,New,"+$54,000",,,,,RGLS
94,,2017-12-06 19:38:49,2017-12-04,RGLS,Rastetter William H,Dir,A - Grant,$0.89,69662,694387,+11%,"+$61,999",,,,,RGLS
95,,2017-07-25 18:09:51,2017-07-25,RGLS,Wright Timothy Michael,"Chief R, D Officer",P - Purchase,$0.91,274725,274725,New,"+$250,000",,,,,RGLS
96,,2017-07-25 18:09:05,2017-07-25,RGLS,Rastetter William H,Dir,P - Purchase,$0.91,274725,624625,+79%,"+$250,000",,,,,RGLS
97,,2017-07-25 18:08:18,2017-07-25,RGLS,Hagan Joseph P,"Pres, CEO",P - Purchase,$0.91,219780,241297,>999%,"+$200,000",,,,,RGLS
98,,2017-07-25 18:07:23,2017-07-25,RGLS,Chevallard Daniel R.,CFO,P - Purchase,$0.91,54945,59415,>999%,"+$50,000",,,,,RGLS
99,,2017-07-25 18:06:39,2017-07-25,RGLS,Papadopoulos Stelios,Dir,P - Purchase,$0.91,1000000,1770677,+130%,"+$910,000",,,,,RGLS
100,M,2017-03-23 16:26:15,2017-03-21,RGLS,Papadopoulos Stelios,Dir,P - Purchase,$1.22,500000,700677,+249%,"+$607,900",12.0,32.0,12.0,,RGLS
101,,2017-03-07 16:59:54,2017-03-07,RGLS,Rastetter William H,Dir,P - Purchase,$1.15,250000,350000,+250%,"+$287,500",13.0,18.0,40.0,,RGLS
102,,2016-03-07 17:20:31,2016-03-03,RGLS,Hagan Joseph P,COO,P - Purchase,$7.19,10000,10000,New,"+$71,900",-6.0,-13.0,5.0,-64.0,RGLS
103,,2016-02-24 18:20:34,2016-02-23,RGLS,"Alnylam Pharmaceuticals, Inc.",10%,S - Sale,$7.18,-1000000,4896716,-17%,"-$7,180,000",-6.0,2.0,-5.0,-48.0,RGLS
104,,2015-08-13 18:10:15,2015-08-13,RGLS,Foletta Mark G,Dir,P - Purchase,$7.64,10000,10000,New,"+$76,405",-1.0,1.0,20.0,-19.0,RGLS
105,D,2015-08-07 18:05:01,2015-08-07,RGLS,Papadopoulos Stelios,Dir,M - OptEx,$1.55,50677,200677,+34%,"+$78,801",1.0,5.0,24.0,-15.0,RGLS
106,M,2015-07-21 20:47:53,2015-07-20,RGLS,Rastetter William H,Dir,P - Purchase,$10.17,100000,100000,New,"+$1,016,978",-7.0,-15.0,-26.0,-40.0,RGLS
107,M,2015-07-17 18:08:34,2015-07-15,RGLS,Isis Pharmaceuticals Inc,10%,S - Sale,$10.60,-343133,5173172,-6%,"-$3,636,078",1.0,-9.0,-28.0,-36.0,RGLS
108,,2015-07-02 16:28:40,2015-06-23,RGLS,Isis Pharmaceuticals Inc,10%,G - Gift,$0.00,13248,5516305,0%,+$0,1.0,-3.0,-19.0,-9.0,RGLS
109,,2015-07-02 16:28:40,2015-06-30,RGLS,Isis Pharmaceuticals Inc,10%,S - Sale,$10.79,-13248,5516305,0%,"-$143,010",1.0,-3.0,-19.0,-9.0,RGLS
110,DM,2015-04-21 19:06:32,2015-04-17,RGLS,Xanthopoulos Kleanthis G,"Pres, CEO",M - OptEx,$0.38,200000,83921,-172%,"+$76,000",-1.0,-18.0,-26.0,-61.0,RGLS
111,DM,2015-04-21 19:06:32,2015-04-17,RGLS,Xanthopoulos Kleanthis G,"Pres, CEO",S - Sale+OE,$17.15,-200000,83921,-70%,"-$3,429,497",-1.0,-18.0,-26.0,-61.0,RGLS
112,D,2015-04-14 17:12:32,2015-04-13,RGLS,Carter Bruce L A,Dir,M - OptEx,$4.78,20000,0,-100%,"+$95,600",1.0,0.0,-22.0,-59.0,RGLS
113,D,2015-04-14 17:12:32,2015-04-13,RGLS,Carter Bruce L A,Dir,S - Sale+OE,$17.66,-20000,0,-100%,"-$353,164",1.0,0.0,-22.0,-59.0,RGLS
114,D,2015-03-05 19:17:24,2015-03-05,RGLS,Xanthopoulos Kleanthis G,"Pres, CEO",M - OptEx,$0.38,89230,82682,-1363%,"+$33,907",-2.0,-8.0,-22.0,-69.0,RGLS
115,D,2015-03-05 19:17:24,2015-03-05,RGLS,Xanthopoulos Kleanthis G,"Pres, CEO",S - Sale+OE,$20.26,-89230,82682,-52%,"-$1,808,063",-2.0,-8.0,-22.0,-69.0,RGLS
116,D,2015-03-03 17:27:43,2015-02-27,RGLS,Xanthopoulos Kleanthis G,"Pres, CEO",M - OptEx,$0.38,70,82682,0%,+$27,1.0,8.0,-7.0,-54.0,RGLS
117,D,2015-03-03 17:27:43,2015-02-27,RGLS,Xanthopoulos Kleanthis G,"Pres, CEO",S - Sale+OE,$19.50,-70,82682,0%,"-$1,365",1.0,8.0,-7.0,-54.0,RGLS
118,DM,2015-02-03 17:39:14,2015-01-30,RGLS,Xanthopoulos Kleanthis G,"Pres, CEO",M - OptEx,$0.38,5700,82682,+7%,"+$2,166",-4.0,-11.0,4.0,-53.0,RGLS
119,DM,2015-02-03 17:39:14,2015-01-30,RGLS,Xanthopoulos Kleanthis G,"Pres, CEO",S - Sale+OE,$19.61,-5700,82682,-6%,"-$111,791",-4.0,-11.0,4.0,-53.0,RGLS
120,,2015-01-30 17:45:43,2015-01-28,RGLS,Gibson Neil W,Chief Scientific Officer,S - Sale,$18.05,-80000,0,-100%,"-$1,444,304",-4.0,-10.0,-3.0,-59.0,RGLS
121,DM,2015-01-30 17:22:28,2015-01-28,RGLS,Xanthopoulos Kleanthis G,"Pres, CEO",M - OptEx,$0.38,145000,82682,-233%,"+$55,100",-4.0,-10.0,-3.0,-59.0,RGLS
122,DM,2015-01-30 17:22:28,2015-01-28,RGLS,Xanthopoulos Kleanthis G,"Pres, CEO",S - Sale+OE,$18.06,-145000,82682,-64%,"-$2,619,150",-4.0,-10.0,-3.0,-59.0,RGLS
123,D,2014-12-15 12:58:18,2014-12-12,RGLS,Papadopoulos Stelios,Dir,M - OptEx,$0.38,150000,150000,New,"+$57,000",-4.0,4.0,12.0,-33.0,RGLS
124,D,2014-12-01 16:49:18,2014-11-28,RGLS,Gibson Neil W,Chief Scientific Officer,M - OptEx,$1.74,2500,80000,+3%,"+$4,350",0.0,-2.0,-9.0,-33.0,RGLS
125,D,2014-12-01 16:49:18,2014-11-28,RGLS,Gibson Neil W,Chief Scientific Officer,S - Sale+OE,$19.30,-2500,80000,-3%,"-$48,245",0.0,-2.0,-9.0,-33.0,RGLS
126,,2014-11-14 16:05:16,2014-11-12,RGLS,Astrazeneca Plc,10%,S - Sale,$17.00,-2000000,4250000,-32%,"-$34,000,000",-2.0,-8.0,-10.0,-26.0,RGLS
127,,2014-11-05 18:48:15,2014-11-03,RGLS,Isis Pharmaceuticals Inc,10%,S - Sale,$15.94,-1279411,5516305,-19%,"-$20,390,613",3.0,7.0,-8.0,-30.0,RGLS
128,D,2014-10-31 16:52:13,2014-10-29,RGLS,Xanthopoulos Kleanthis G,"Pres, CEO",M - OptEx,$0.38,3505,82682,+4%,"+$1,332",1.0,-2.0,-12.0,-35.0,RGLS
129,D,2014-10-31 16:52:13,2014-10-29,RGLS,Xanthopoulos Kleanthis G,"Pres, CEO",S - Sale+OE,$19.35,-3505,82682,-4%,"-$67,824",1.0,-2.0,-12.0,-35.0,RGLS
130,D,2014-10-31 16:50:27,2014-10-29,RGLS,Gibson Neil W,Chief Scientific Officer,M - OptEx,$1.74,2500,80000,+3%,"+$4,350",1.0,-2.0,-12.0,-35.0,RGLS
131,D,2014-10-31 16:50:27,2014-10-29,RGLS,Gibson Neil W,Chief Scientific Officer,S - Sale+OE,$19.29,-2500,80000,-3%,"-$48,234",1.0,-2.0,-12.0,-35.0,RGLS
132,AM,2014-10-28 17:03:32,2014-10-22,RGLS,Isis Pharmaceuticals Inc,"Dir, 10%",S - Sale,$14.02,-113084,6795716,-2%,"-$1,585,447",3.0,13.0,-1.0,-24.0,RGLS
133,AM,2014-10-28 16:59:34,2014-10-22,RGLS,"Alnylam Pharmaceuticals, Inc.",10%,S - Sale,$14.02,-113084,5896716,-2%,"-$1,585,447",3.0,13.0,-1.0,-24.0,RGLS
134,M,2014-10-24 21:29:33,2014-10-22,RGLS,Isis Pharmaceuticals Inc,"Dir, 10%",S - Sale,$14.02,-113084,6795716,-2%,"-$1,585,437",6.0,6.0,-8.0,-19.0,RGLS
135,M,2014-10-24 21:27:23,2014-10-22,RGLS,"Alnylam Pharmaceuticals, Inc.",10%,S - Sale,$14.02,-113084,5896716,-2%,"-$1,585,437",6.0,6.0,-8.0,-19.0,RGLS
136,D,2014-10-24 16:16:09,2014-10-22,RGLS,Gibson Neil W,Chief Scientific Officer,M - OptEx,$1.74,3300,80000,+4%,"+$5,742",6.0,6.0,-8.0,-19.0,RGLS
137,D,2014-10-24 16:16:09,2014-10-22,RGLS,Gibson Neil W,Chief Scientific Officer,S - Sale+OE,$14.44,-3300,80000,-4%,"-$47,644",6.0,6.0,-8.0,-19.0,RGLS
138,DM,2014-10-21 16:07:28,2014-10-17,RGLS,Xanthopoulos Kleanthis G,"Pres, CEO",M - OptEx,$0.38,700,82682,+1%,+$266,103.0,172.0,166.0,156.0,RGLS
139,DM,2014-10-21 16:07:28,2014-10-17,RGLS,Xanthopoulos Kleanthis G,"Pres, CEO",S - Sale+OE,$7.02,-700,82682,-1%,"-$4,916",103.0,172.0,166.0,156.0,RGLS
140,M,2014-10-17 17:38:14,2014-10-15,RGLS,Isis Pharmaceuticals Inc,"Dir, 10%",S - Sale,$6.74,-12100,6908800,0%,"-$81,508",3.0,114.0,153.0,152.0,RGLS
141,M,2014-10-17 17:37:37,2014-10-15,RGLS,"Alnylam Pharmaceuticals, Inc.",10%,S - Sale,$6.74,-12100,6009800,0%,"-$81,508",3.0,114.0,153.0,152.0,RGLS
142,DM,2014-10-14 17:54:05,2014-10-09,RGLS,Xanthopoulos Kleanthis G,"Pres, CEO",M - OptEx,$0.38,505,82682,+1%,+$192,-2.0,1.0,208.0,160.0,RGLS
143,DM,2014-10-14 17:54:05,2014-10-09,RGLS,Xanthopoulos Kleanthis G,"Pres, CEO",S - Sale+OE,$7.00,-505,82682,-1%,"-$3,535",-2.0,1.0,208.0,160.0,RGLS
144,M,2014-10-10 18:26:29,2014-10-08,RGLS,Isis Pharmaceuticals Inc,"Dir, 10%",S - Sale,$6.56,-10050,6920900,0%,"-$65,938",4.0,9.0,241.0,172.0,RGLS
145,M,2014-10-10 18:25:37,2014-10-08,RGLS,"Alnylam Pharmaceuticals, Inc.",10%,S - Sale,$6.56,-10050,6021900,0%,"-$65,938",4.0,9.0,241.0,172.0,RGLS
146,M,2014-10-03 17:20:30,2014-10-01,RGLS,Isis Pharmaceuticals Inc,"Dir, 10%",S - Sale,$6.74,-10300,6930950,0%,"-$69,399",-2.0,-5.0,192.0,139.0,RGLS
147,M,2014-10-03 17:19:38,2014-10-01,RGLS,"Alnylam Pharmaceuticals, Inc.",10%,S - Sale,$6.74,-10300,6031950,0%,"-$69,399",-2.0,-5.0,192.0,139.0,RGLS
148,D,2014-10-02 19:17:08,2014-09-30,RGLS,Xanthopoulos Kleanthis G,"Pres, CEO",M - OptEx,$0.38,2300,82682,+3%,+$874,1.0,2.0,172.0,153.0,RGLS
149,D,2014-10-02 19:17:08,2014-09-30,RGLS,Xanthopoulos Kleanthis G,"Pres, CEO",S - Sale+OE,$7.02,-2300,82682,-3%,"-$16,137",1.0,2.0,172.0,153.0,RGLS
150,M,2014-09-26 17:37:47,2014-09-24,RGLS,"Alnylam Pharmaceuticals, Inc.",10%,S - Sale,$7.13,-8750,6042250,0%,"-$62,367",0.0,-4.0,145.0,138.0,RGLS
151,M,2014-09-26 17:36:49,2014-09-24,RGLS,Isis Pharmaceuticals Inc,"Dir, 10%",S - Sale,$7.13,-8750,6941250,0%,"-$62,367",0.0,-4.0,145.0,138.0,RGLS
152,M,2014-09-19 17:10:36,2014-09-17,RGLS,Isis Pharmaceuticals Inc,"Dir, 10%",S - Sale,$7.31,-7700,6950000,0%,"-$56,294",-2.0,0.0,-5.0,153.0,RGLS
153,M,2014-09-19 17:09:44,2014-09-17,RGLS,"Alnylam Pharmaceuticals, Inc.",10%,S - Sale,$7.31,-7700,6051000,0%,"-$56,294",-2.0,0.0,-5.0,153.0,RGLS
154,DM,2014-09-15 17:14:26,2014-09-11,RGLS,Gibson Neil W,Chief Scientific Officer,M - OptEx,$1.74,4200,80000,+6%,"+$7,308",-2.0,-7.0,-12.0,147.0,RGLS
155,DM,2014-09-15 17:14:26,2014-09-11,RGLS,Gibson Neil W,Chief Scientific Officer,S - Sale+OE,$8.01,-4200,80000,-5%,"-$33,627",-2.0,-7.0,-12.0,147.0,RGLS
156,M,2014-09-12 18:26:10,2014-09-10,RGLS,Isis Pharmaceuticals Inc,"Dir, 10%",S - Sale,$7.85,-8900,6957700,0%,"-$69,896",-4.0,-7.0,-19.0,139.0,RGLS
157,M,2014-09-12 18:24:35,2014-09-10,RGLS,"Alnylam Pharmaceuticals, Inc.",10%,S - Sale,$7.85,-8900,6058700,0%,"-$69,896",-4.0,-7.0,-19.0,139.0,RGLS
158,M,2014-09-05 18:52:04,2014-09-03,RGLS,"Alnylam Pharmaceuticals, Inc.",10%,S - Sale,$7.07,-10050,6067600,0%,"-$71,102",4.0,13.0,-3.0,190.0,RGLS
159,M,2014-09-05 17:57:18,2014-09-03,RGLS,Isis Pharmaceuticals Inc,"Dir, 10%",S - Sale,$7.07,-10050,6966600,0%,"-$71,102",4.0,13.0,-3.0,190.0,RGLS
160,M,2014-08-29 19:13:18,2014-08-27,RGLS,Isis Pharmaceuticals Inc,"Dir, 10%",S - Sale,$7.00,-5000,6976650,0%,"-$34,996",2.0,4.0,4.0,172.0,RGLS
161,M,2014-08-29 19:12:35,2014-08-27,RGLS,"Alnylam Pharmaceuticals, Inc.",10%,S - Sale,$7.00,-5000,6077650,0%,"-$34,996",2.0,4.0,4.0,172.0,RGLS
162,D,2014-08-29 17:19:53,2014-08-28,RGLS,Xanthopoulos Kleanthis G,"Pres, CEO",M - OptEx,$0.38,3505,80216,+5%,"+$1,332",2.0,4.0,4.0,172.0,RGLS
163,D,2014-08-29 17:19:53,2014-08-28,RGLS,Xanthopoulos Kleanthis G,"Pres, CEO",S - Sale+OE,$7.06,-3505,80216,-4%,"-$24,754",2.0,4.0,4.0,172.0,RGLS
164,M,2014-08-22 19:23:28,2014-08-20,RGLS,"Alnylam Pharmaceuticals, Inc.",10%,S - Sale,$6.89,-10750,6082650,0%,"-$74,089",2.0,0.0,2.0,171.0,RGLS
165,M,2014-08-22 19:22:11,2014-08-20,RGLS,Isis Pharmaceuticals Inc,"Dir, 10%",S - Sale,$6.89,-10750,6981650,0%,"-$74,089",2.0,0.0,2.0,171.0,RGLS
166,M,2014-08-15 19:12:00,2014-08-13,RGLS,"Alnylam Pharmaceuticals, Inc.",10%,S - Sale,$7.01,-5450,6093400,0%,"-$38,227",4.0,-2.0,7.0,139.0,RGLS
167,M,2014-08-15 19:11:04,2014-08-13,RGLS,Isis Pharmaceuticals Inc,"Dir, 10%",S - Sale,$7.01,-5450,6992400,0%,"-$38,227",4.0,-2.0,7.0,139.0,RGLS
168,M,2014-08-08 20:15:54,2014-08-06,RGLS,Isis Pharmaceuticals Inc,"Dir, 10%",S - Sale,$6.87,-7600,6997850,0%,"-$52,205",4.0,4.0,9.0,150.0,RGLS
169,M,2014-08-08 20:08:30,2014-08-06,RGLS,"Alnylam Pharmaceuticals, Inc.",10%,S - Sale,$6.87,-7600,6098850,0%,"-$52,205",4.0,4.0,9.0,150.0,RGLS
170,D,2014-08-07 17:51:54,2014-08-05,RGLS,Xanthopoulos Kleanthis G,"Pres, CEO",M - OptEx,$0.38,3505,80216,+5%,"+$1,332",1.0,5.0,6.0,149.0,RGLS
171,D,2014-08-07 17:51:54,2014-08-05,RGLS,Xanthopoulos Kleanthis G,"Pres, CEO",S - Sale+OE,$7.06,-3505,80216,-4%,"-$24,739",1.0,5.0,6.0,149.0,RGLS
172,M,2014-08-01 18:52:36,2014-07-30,RGLS,"Alnylam Pharmaceuticals, Inc.",10%,S - Sale,$6.35,-5350,6106450,0%,"-$33,989",7.0,8.0,11.0,203.0,RGLS
173,M,2014-08-01 18:44:26,2014-07-30,RGLS,Isis Pharmaceuticals Inc,"Dir, 10%",S - Sale,$6.35,-5350,7005450,0%,"-$33,989",7.0,8.0,11.0,203.0,RGLS
174,M,2014-07-25 20:41:58,2014-07-23,RGLS,Isis Pharmaceuticals Inc,"Dir, 10%",S - Sale,$6.75,-5250,7010800,0%,"-$35,436",-4.0,-2.0,4.0,178.0,RGLS
175,M,2014-07-25 20:40:10,2014-07-23,RGLS,"Alnylam Pharmaceuticals, Inc.",10%,S - Sale,$6.75,-5250,6111800,0%,"-$35,436",-4.0,-2.0,4.0,178.0,RGLS
176,M,2014-07-18 19:19:32,2014-07-16,RGLS,Isis Pharmaceuticals Inc,"Dir, 10%",S - Sale,$6.66,-13500,7016050,0%,"-$89,965",-1.0,0.0,4.0,151.0,RGLS
177,M,2014-07-18 19:17:23,2014-07-16,RGLS,"Alnylam Pharmaceuticals, Inc.",10%,S - Sale,$6.66,-13500,6117050,0%,"-$89,965",-1.0,0.0,4.0,151.0,RGLS
178,M,2014-07-11 20:25:40,2014-07-09,RGLS,Isis Pharmaceuticals Inc,"Dir, 10%",S - Sale,$6.73,-8050,7029550,0%,"-$54,196",2.0,2.0,5.0,200.0,RGLS
179,M,2014-07-11 20:25:35,2014-07-09,RGLS,"Alnylam Pharmaceuticals, Inc.",10%,S - Sale,$6.73,-8050,6130550,0%,"-$54,196",2.0,2.0,5.0,200.0,RGLS
180,M,2014-07-07 17:19:39,2014-07-02,RGLS,"Alnylam Pharmaceuticals, Inc.",10%,S - Sale,$8.07,-4300,6138600,0%,"-$34,689",-3.0,-10.0,-9.0,121.0,RGLS
181,M,2014-07-07 17:14:48,2014-07-02,RGLS,Isis Pharmaceuticals Inc,10%,S - Sale,$8.07,-4300,7037600,0%,"-$34,689",-3.0,-10.0,-9.0,121.0,RGLS
182,D,2014-07-02 16:39:52,2014-07-01,RGLS,Gibson Neil W,Chief Scientific Officer,M - OptEx,$1.74,2500,80000,+3%,"+$4,350",1.0,-10.0,-20.0,99.0,RGLS
183,D,2014-07-02 16:39:52,2014-07-01,RGLS,Gibson Neil W,Chief Scientific Officer,S - Sale+OE,$8.10,-2500,80000,-3%,"-$20,260",1.0,-10.0,-20.0,99.0,RGLS
184,D,2014-07-02 16:35:38,2014-07-01,RGLS,Xanthopoulos Kleanthis G,"Pres, CEO",M - OptEx,$0.38,3505,80216,+5%,"+$1,332",1.0,-10.0,-20.0,99.0,RGLS
185,D,2014-07-02 16:35:38,2014-07-01,RGLS,Xanthopoulos Kleanthis G,"Pres, CEO",S - Sale+OE,$8.11,-3505,80216,-4%,"-$28,426",1.0,-10.0,-20.0,99.0,RGLS
186,M,2014-06-27 19:00:19,2014-06-25,RGLS,Isis Pharmaceuticals Inc,10%,S - Sale,$7.88,-7600,7041900,0%,"-$59,905",2.0,3.0,-20.0,87.0,RGLS
187,M,2014-06-27 18:45:23,2014-06-25,RGLS,"Alnylam Pharmaceuticals, Inc.",10%,S - Sale,$7.88,-7600,6142900,0%,"-$59,905",2.0,3.0,-20.0,87.0,RGLS
188,D,2014-06-18 17:54:06,2014-06-17,RGLS,Gibson Neil W,Chief Scientific Officer,M - OptEx,$1.74,5000,80000,+7%,"+$8,700",2.0,-4.0,-19.0,91.0,RGLS
189,D,2014-06-18 17:54:06,2014-06-17,RGLS,Gibson Neil W,Chief Scientific Officer,S - Sale+OE,$8.05,-5000,80000,-6%,"-$40,227",2.0,-4.0,-19.0,91.0,RGLS
190,D,2014-06-09 19:31:46,2014-06-09,RGLS,Xanthopoulos Kleanthis G,"Pres, CEO",M - OptEx,$0.38,3505,80216,+5%,"+$1,332",-1.0,0.0,-1.0,148.0,RGLS
191,D,2014-06-09 19:31:46,2014-06-09,RGLS,Xanthopoulos Kleanthis G,"Pres, CEO",S - Sale+OE,$7.14,-3505,80216,-4%,"-$25,017",-1.0,0.0,-1.0,148.0,RGLS
192,DM,2014-05-29 19:57:44,2014-05-27,RGLS,Xanthopoulos Kleanthis G,"Pres, CEO",M - OptEx,$0.38,3505,80216,+5%,"+$1,332",-2.0,-11.0,16.0,159.0,RGLS
193,DM,2014-05-29 19:57:44,2014-05-27,RGLS,Xanthopoulos Kleanthis G,"Pres, CEO",S - Sale+OE,$7.00,-3505,80216,-4%,"-$24,538",-2.0,-11.0,16.0,159.0,RGLS
194,D,2014-04-10 14:51:47,2014-04-09,RGLS,Gibson Neil W,Chief Scientific Officer,M - OptEx,$1.74,2500,80000,+3%,"+$4,350",-5.0,-15.0,-21.0,-15.0,RGLS
195,D,2014-04-10 14:51:47,2014-04-09,RGLS,Gibson Neil W,Chief Scientific Officer,S - Sale+OE,$8.11,-2500,80000,-3%,"-$20,271",-5.0,-15.0,-21.0,-15.0,RGLS
196,D,2014-04-09 14:02:24,2014-03-06,RGLS,Xanthopoulos Kleanthis G,"Pres, CEO",M - OptEx,$0.38,3505,80216,+5%,"+$1,332",7.0,-12.0,-24.0,-15.0,RGLS
197,D,2014-04-09 14:02:24,2014-03-06,RGLS,Xanthopoulos Kleanthis G,"Pres, CEO",S - Sale+OE,$7.60,-3505,80216,-4%,"-$26,623",7.0,-12.0,-24.0,-15.0,RGLS
198,D,2014-03-07 14:33:08,2014-03-06,RGLS,Xanthopoulos Kleanthis G,"Pres, CEO",M - OptEx,$0.38,3505,80216,+5%,"+$1,332",-3.0,2.0,-31.0,-32.0,RGLS
199,D,2014-03-07 14:33:08,2014-03-06,RGLS,Xanthopoulos Kleanthis G,"Pres, CEO",S - Sale+OE,$11.35,-3505,80216,-4%,"-$39,778",-3.0,2.0,-31.0,-32.0,RGLS
200,D,2014-03-07 14:29:22,2014-03-06,RGLS,Gibson Neil W,Chief Scientific Officer,M - OptEx,$1.74,2500,80000,+3%,"+$4,350",-3.0,2.0,-31.0,-32.0,RGLS
201,D,2014-03-07 14:29:22,2014-03-06,RGLS,Gibson Neil W,Chief Scientific Officer,S - Sale+OE,$11.37,-2500,80000,-3%,"-$28,429",-3.0,2.0,-31.0,-32.0,RGLS
202,D,2014-02-07 15:09:34,2014-02-05,RGLS,Xanthopoulos Kleanthis G,"Pres, CEO",M - OptEx,$0.38,3505,80216,+5%,"+$1,332",3.0,11.0,24.0,-20.0,RGLS
203,D,2014-02-07 15:09:34,2014-02-05,RGLS,Xanthopoulos Kleanthis G,"Pres, CEO",S - Sale+OE,$8.40,-3505,80216,-4%,"-$29,437",3.0,11.0,24.0,-20.0,RGLS
204,DM,2014-02-07 15:04:29,2014-02-05,RGLS,Gibson Neil W,Chief Scientific Officer,M - OptEx,$1.74,47500,80000,+146%,"+$82,650",3.0,11.0,24.0,-20.0,RGLS
205,D,2014-02-07 15:04:29,2014-02-05,RGLS,Gibson Neil W,Chief Scientific Officer,S - Sale+OE,$8.38,-17500,80000,-18%,"-$146,706",3.0,11.0,24.0,-20.0,RGLS
206,,2014-02-05 15:38:45,2014-02-04,RGLS,Sanofi,10%,P - Purchase,$7.67,1303780,5053779,+35%,"+$9,999,993",-5.0,7.0,22.0,-18.0,RGLS
207,D,2014-01-23 14:33:07,2014-01-21,RGLS,Gibson Neil W,Chief Scientific Officer,M - OptEx,$2.66,4421,50000,+10%,"+$11,760",3.0,4.0,33.0,-15.0,RGLS
208,D,2014-01-23 14:33:07,2014-01-21,RGLS,Gibson Neil W,Chief Scientific Officer,S - Sale+OE,$8.09,-4421,50000,-8%,"-$35,764",3.0,4.0,33.0,-15.0,RGLS
209,D,2014-01-21 16:03:03,2014-01-17,RGLS,Gibson Neil W,Chief Scientific Officer,M - OptEx,$2.17,4479,50000,+10%,"+$9,706",-6.0,-9.0,22.0,-24.0,RGLS
210,D,2014-01-21 16:03:03,2014-01-17,RGLS,Gibson Neil W,Chief Scientific Officer,S - Sale+OE,$8.15,-4479,50000,-8%,"-$36,494",-6.0,-9.0,22.0,-24.0,RGLS
211,D,2014-01-17 13:35:42,2014-01-16,RGLS,Gibson Neil W,Chief Scientific Officer,M - OptEx,$1.74,1100,50000,+2%,"+$1,914",0.0,1.0,25.0,-14.0,RGLS
212,D,2014-01-17 13:35:42,2014-01-16,RGLS,Gibson Neil W,Chief Scientific Officer,S - Sale+OE,$8.03,-1100,50000,-2%,"-$8,837",0.0,1.0,25.0,-14.0,RGLS
213,D,2014-01-02 20:52:02,2014-01-02,RGLS,Xanthopoulos Kleanthis G,"Pres, CEO",M - OptEx,$0.38,3505,80216,+5%,"+$1,332",-3.0,-4.0,24.0,9.0,RGLS
214,D,2014-01-02 20:52:02,2014-01-02,RGLS,Xanthopoulos Kleanthis G,"Pres, CEO",S - Sale+OE,$7.25,-3505,80216,-4%,"-$25,408",-3.0,-4.0,24.0,9.0,RGLS
215,D,2013-12-16 20:47:12,2013-12-16,RGLS,Xanthopoulos Kleanthis G,"Pres, CEO",G - Gift,$0.00,-2000,80216,-2%,-$0,-1.0,-1.0,9.0,18.0,RGLS
216,D,2013-02-14 21:08:13,2013-02-04,RGLS,Gibson Neil W,Chief Scientific Officer,M - OptEx,$1.74,50000,50000,New,"+$87,000",-5.0,-9.0,19.0,57.0,RGLS
217,D,2012-10-11 19:58:44,2012-10-10,RGLS,"Alnylam Pharmaceuticals, Inc.",10%,C - Converted deriv,$0.00,6150500,6150500,-50%,$0,2.0,1.0,18.0,71.0,RGLS
218,D,2012-10-11 19:58:18,2012-10-10,RGLS,Greene Barry E,"Dir, 10%",C - Converted deriv,$0.00,6150500,6150500,-50%,$0,2.0,1.0,18.0,71.0,RGLS
219,D,2012-10-11 19:56:16,2012-10-10,RGLS,Isis Pharmaceuticals Inc,10%,C - Converted deriv,$0.00,6299500,7049500,-47%,$0,2.0,1.0,18.0,71.0,RGLS
220,D,2012-10-11 19:56:16,2012-10-10,RGLS,Isis Pharmaceuticals Inc,10%,P - Purchase,$4.00,750000,7049500,+12%,"+$3,000,000",2.0,1.0,18.0,71.0,RGLS
221,D,2012-10-11 19:53:15,2012-10-10,RGLS,Parshall B Lynne,"Dir, 10%",C - Converted deriv,$0.00,6299500,7049500,-47%,$0,2.0,1.0,18.0,71.0,RGLS
222,D,2012-10-11 19:53:15,2012-10-10,RGLS,Parshall B Lynne,"Dir, 10%",P - Purchase,$4.00,750000,7049500,+12%,"+$3,000,000",2.0,1.0,18.0,71.0,RGLS
223,D,2012-10-11 19:52:16,2012-10-10,RGLS,Crooke Stanley T,"Dir, 10%",C - Converted deriv,$0.00,6299500,7049500,-47%,$0,2.0,1.0,18.0,71.0,RGLS
224,D,2012-10-11 19:52:16,2012-10-10,RGLS,Crooke Stanley T,"Dir, 10%",P - Purchase,$4.00,750000,7049500,+12%,"+$3,000,000",2.0,1.0,18.0,71.0,RGLS
225,D,2012-10-11 19:52:01,2012-10-10,RGLS,Maraganore John,"Dir, 10%",C - Converted deriv,$0.00,6150500,6150500,-50%,$0,2.0,1.0,18.0,71.0,RGLS
